Response to subdermal implantation of textured microimplants in humans.
In lieu of the problems involved with the use of foreign substances such as ivory, paraffin, liquid silicone, and collagen, a new subcutaneous injectable device has been developed. This material--Bioplastique--has been developed in an attempt to overcome the shortcomings of previous augmentation materials, most notably absorption, migration, and immunologic rejection. This article presents a longitudinal study of the use of this new microimplant.
Allen
O
O
D001672:Biocompatible Materials; D004848:Epithelium / Q000473:pathology; D005549:Foreign-Body Reaction / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000473:pathology; D008137:Longitudinal Studies; D011108:Polymers; D019736:Prostheses and Implants
D001672:Biocompatible Materials; C068018:Bioplastique; D011108:Polymers